TY - JOUR
T1 - Making informed decisions about prostate cancer testing
T2 - locally tailored factsheets on the burden of prostate cancer in Australia
AU - Chiam, Karen
AU - Crowe, Jane
AU - Grogan, Paul
AU - Vaneckova, Pavla
AU - Kohar, Ankur
AU - Mazariego, Carolyn
AU - Nair-Shalliker, Visalini
AU - Smith, David P.
PY - 2023/3
Y1 - 2023/3
N2 - PROSTATE-SPECIFIC ANTIGEN (PSA) testing for the early detection of prostate cancer has been a contentious topic for several decades. Evidence suggests that PSA testing is unlikely to be suitable as a population-based screening program due to inconsistent information relating to the relative benefits and harms of testing on mortality. A shared informed decisionmaking consultation between men and their general practitioners (GPs) to discuss the benefits and risks of PSA testing is required.
AB - PROSTATE-SPECIFIC ANTIGEN (PSA) testing for the early detection of prostate cancer has been a contentious topic for several decades. Evidence suggests that PSA testing is unlikely to be suitable as a population-based screening program due to inconsistent information relating to the relative benefits and harms of testing on mortality. A shared informed decisionmaking consultation between men and their general practitioners (GPs) to discuss the benefits and risks of PSA testing is required.
UR - http://www.scopus.com/inward/record.url?scp=85149501323&partnerID=8YFLogxK
U2 - 10.31128/AJGP-07-22-6500
DO - 10.31128/AJGP-07-22-6500
M3 - Article
C2 - 36872086
AN - SCOPUS:85149501323
SN - 2208-794X
VL - 52
SP - 102
EP - 105
JO - Australian Journal of General Practice
JF - Australian Journal of General Practice
IS - 3
ER -